The budget reconciliation bill passed the House of Representatives by a one-vote margin, 215 to 214, and soon will be considered by Senate committees. The day before the House vote, the Rules Committee...
State regulations on housing discrimination protect individuals even when they are not otherwise included under federal law. Explore this U.S. 50 state, District of Columbia, and U.S. territories law survey...
Artificial intelligence (AI) is no longer a future consideration—it’s a core component of how businesses operate today. From automating workflows to powering proprietary tools, AI is reshaping...
This checklist covers the applicability of artificial intelligence (AI) in areas critical to life sciences and healthcare companies, including data privacy, intellectual property, and research and development...
Do you need to understand key labor and employment considerations for companies and their legal counsel navigating mergers and acquisitions and other business transactions? Review our recently published...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Shadow trading is a novel form of insider trading that the SEC is arguing in an ongoing civil case against a pharmaceutical company executive. Shadow trading refers to an insider’s use of material nonpublic information (MNPI) about their company to make trades in another company’s stock, based on an expected increase in the other company’s stock after an announcement of the MNPI. Listen to this podcast episode for more information about the case, the arguments being made, and possible implications if the SEC prevails.
Listen now »
Related Content
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+